3

FORM 3 SUBMISSION

Company: VERTEX PHARMACEUTICALS INC / MA
Filed: May 18, 2022
Period of Report: May 18, 2022
Accession Number: 0000899243-22-018592

View Document ↗ View on SEC.gov ↗